Lynn S. Cheng

710 total citations · 1 hit paper
7 papers, 591 citations indexed

About

Lynn S. Cheng is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Lynn S. Cheng has authored 7 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Lynn S. Cheng's work include Cancer-related Molecular Pathways (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Lynn S. Cheng is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Lynn S. Cheng collaborates with scholars based in Canada, Brazil and United Kingdom. Lynn S. Cheng's co-authors include Meredith S. Irwin, William G. Kaelin, William C. Hahn, María C. Marín, Keiichi Kondo, Alvaro Blanch, Ian R. Watson, David R. Kaplan, Loen M. Hansford and Sylvain Baruchel and has published in prestigious journals such as PLoS ONE, Cancer Cell and Oncogene.

In The Last Decade

Lynn S. Cheng

7 papers receiving 581 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemosensitivity linked to p73 function

2003 345 citations Meredith S. Irwin, Keiichi Kondo et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn S. Cheng Canada	7	421	359	125	95	56	7	591
Gunnar Steinert Germany	11	197 0.5×	334 0.9×	42 0.3×	255 2.7×	18 0.3×	13	575
Linda K. Woods United States	7	353 0.8×	164 0.5×	39 0.3×	104 1.1×	11 0.2×	10	624
Jean-Pierre Roperch France	9	335 0.8×	164 0.5×	15 0.1×	71 0.7×	25 0.4×	10	503
Gabriel L. Fiszman Argentina	14	258 0.6×	195 0.5×	29 0.2×	73 0.8×	53 0.9×	26	512
Martin R. Graf United States	14	336 0.8×	214 0.6×	28 0.2×	35 0.4×	10 0.2×	25	711
Marisol De La Fuente Mexico	10	234 0.6×	299 0.8×	17 0.1×	101 1.1×	21 0.4×	19	577
BaoHan T. Vo United States	12	335 0.8×	114 0.3×	16 0.1×	107 1.1×	13 0.2×	15	502
Chad R. Schultz United States	15	381 0.9×	110 0.3×	60 0.5×	74 0.8×	4 0.1×	29	644
Rounak Nassirpour United States	10	340 0.8×	101 0.3×	113 0.9×	125 1.3×	7 0.1×	12	573
Jianqun Liao United States	10	340 0.8×	257 0.7×	18 0.1×	149 1.6×	44 0.8×	14	642

Countries citing papers authored by Lynn S. Cheng

Since Specialization

Citations

This map shows the geographic impact of Lynn S. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn S. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn S. Cheng more than expected).

Fields of papers citing papers by Lynn S. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn S. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn S. Cheng. The network helps show where Lynn S. Cheng may publish in the future.

Co-authorship network of co-authors of Lynn S. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn S. Cheng. A scholar is included among the top collaborators of Lynn S. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn S. Cheng. Lynn S. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Blanch, Alvaro, et al.. (2013). Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity. PLoS ONE. 8(6). e66436–e66436. 57 indexed citations

2.

Wolter, Nikolaus E., Alvaro Blanch, Lynn S. Cheng, et al.. (2013). Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget. 5(1). 161–172. 61 indexed citations

3.

Chung, Jacky, Joanne Lau, Lynn S. Cheng, et al.. (2010). SATB2 augments ΔNp63α in head and neck squamous cell carcinoma. EMBO Reports. 11(10). 777–783. 45 indexed citations

4.

Lau, Loretta M. S., Joanne Lau, Lynn S. Cheng, et al.. (2009). Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma. Oncogene. 28(19). 2024–2033. 31 indexed citations

5.

Lau, Loretta M. S., Loen M. Hansford, Lynn S. Cheng, et al.. (2006). Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma. Oncogene. 26(13). 1920–1931. 31 indexed citations

6.

Stickle, Natalie, Lynn S. Cheng, Ian R. Watson, et al.. (2005). Expression of p53 in renal carcinoma cells is independent of pVHL. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 578(1-2). 23–32. 21 indexed citations

7.

Irwin, Meredith S., Keiichi Kondo, María C. Marín, et al.. (2003). Chemosensitivity linked to p73 function. Cancer Cell. 3(4). 403–410. 345 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact